| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/26/1997 | EP0764441A1 Cosmetic or dermopharmaceutical patch containing at least one active agent, particularly an unstable one in an oxidative medium, and at least one hydroabsorbent in an anhydrous polymeric matrix |
| 03/26/1997 | EP0764177A1 Cross-linked polymers for removing bile salts from a patient |
| 03/26/1997 | EP0764174A1 Process for removing bile salts from a patient and alkylated compositions therefor |
| 03/26/1997 | EP0764169A2 Drug salts |
| 03/26/1997 | EP0764167A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme |
| 03/26/1997 | EP0764166A1 Corticotropin releasing factor antagonists |
| 03/26/1997 | EP0764163A1 Tachykinin (nk 1) receptor antagonists |
| 03/26/1997 | EP0764162A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
| 03/26/1997 | EP0764161A1 Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria |
| 03/26/1997 | EP0764160A1 Thiopyridines for use in the control of helicobacter bacteria |
| 03/26/1997 | EP0764159A1 C -4 amide substituted compounds and their use as therapeutic agents |
| 03/26/1997 | EP0764158A1 Benzopyrans and their use as therapeutic agents |
| 03/26/1997 | EP0764157A1 Benzopyrans and their use as therapeutic agents |
| 03/26/1997 | EP0764156A1 New taxoids, preparation thereof and pharmaceutical compositions containing them |
| 03/26/1997 | EP0764155A1 Taxoids, preparation and pharmaceutical compositions containing them |
| 03/26/1997 | EP0764154A1 New taxoids, preparation thereof and pharmaceutical compositions containing them |
| 03/26/1997 | EP0764153A1 Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity |
| 03/26/1997 | EP0764152A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 03/26/1997 | EP0764151A2 Purification of serine protease and synthetic inhibitors thereof |
| 03/26/1997 | EP0764149A1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 03/26/1997 | EP0764032A1 Stable gel formulation for topical treatment of skin conditions |
| 03/26/1997 | EP0764028A2 Method of treating retained pulmonary secretions |
| 03/26/1997 | EP0764027A1 Method for protection against genotoxic mutagenesis |
| 03/26/1997 | EP0764026A1 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 03/26/1997 | EP0764025A1 Method and medicine for alleviating jet lag |
| 03/26/1997 | EP0764024A1 Treating conditions with (+)-liarozole |
| 03/26/1997 | EP0764023A1 Compounds and compositions for administration via oral inhalation or insufflation |
| 03/26/1997 | EP0764022A1 Agonists and antagonists of the nicotinic acetylcholine receptors of insects to control endoparasites |
| 03/26/1997 | EP0764021A1 Uterine fibroid treatment |
| 03/26/1997 | EP0764020A1 Transdermal drug delivery system |
| 03/26/1997 | EP0764018A1 Non-steroidal anti-inflammatory ophthalmic suspensions |
| 03/26/1997 | EP0764017A1 Methods and compositions for disrupting the epithelial barrier function |
| 03/26/1997 | EP0723445B1 Analgesic agent and its use |
| 03/26/1997 | EP0696279B1 Oxidation products of cephalomannine |
| 03/26/1997 | EP0695751B1 Agent acting on the central nervous system, process for its preparation and pharmaceutical compositions containing it |
| 03/26/1997 | EP0680470B1 Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 03/26/1997 | EP0666854B1 Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds |
| 03/26/1997 | EP0662975B1 2-substituted adenosines with a-2 receptor affinity |
| 03/26/1997 | EP0649405B1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs |
| 03/26/1997 | EP0639077B1 Drug for increasing the level of testosterone in the body |
| 03/26/1997 | EP0618917B1 1'-amino-2- (benzothiazolyl)methyl]spiro isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors |
| 03/26/1997 | EP0617624B1 Treatment of periodontal disease with alendronate |
| 03/26/1997 | EP0611373B1 Oligo-2'-deoxynucleotides and their use as drugs with an antiviral action |
| 03/26/1997 | EP0539493B1 Targeted drug delivery via phosphonate derivatives |
| 03/26/1997 | CN1146204A Heteroaromatic oxazole compounds and use thereof |
| 03/26/1997 | CN1146202A Quinolone derivative for treatment of urinary incontinence |
| 03/26/1997 | CN1146201A Sulphonamide derivatives as aspartyl protease inhibitors |
| 03/26/1997 | CN1146154A Use of dimeticone for local antibacterial therapy and/or prevention and therapy of helicobacter phylori (HP) associated syndromes and infectious diseases |
| 03/26/1997 | CN1146153A Use of ginsenoside Ro or plant extract containing same to promote collagen synthesis |
| 03/26/1997 | CN1146152A Use of bisphophonates for inhibiting bone resorption following |
| 03/26/1997 | CN1146151A Intranasal antimigraine composition |
| 03/26/1997 | CN1146150A Low dosage ranitidine compositions |
| 03/26/1997 | CN1146149A Analgesic activity enhancer |
| 03/26/1997 | CN1146148A Ranitidine tablet having hydroxypropylmethyl cellulose containing coating and method for producing said coating |
| 03/26/1997 | CN1145908A New aminophenylphosphonic acid compounds, process for preparing them and pharmaceutical compositions containing them |
| 03/26/1997 | CN1145906A Process for production of pharmaceutically acceptable salt of alavulanic acid |
| 03/26/1997 | CN1145904A Production of beta-form thiamine hydrochloride crystals |
| 03/26/1997 | CN1145903A D4T polymorphic form I process |
| 03/26/1997 | CN1145899A Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound |
| 03/26/1997 | CN1145897A New aryl (alkyl) propylamides process for preparing them and pharmaceutical compositions containing them |
| 03/26/1997 | CN1145896A New alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them |
| 03/26/1997 | CN1145895A New amido-ethyl substituted fluorene compound and its prepn. |
| 03/26/1997 | CN1145894A New arylalkyl (thio) carboxamides, processes for preparing them and pharmacetuical compositions containing them |
| 03/26/1997 | CN1145783A Pharmaceutical composition |
| 03/26/1997 | CN1145782A Method of using iron chelating compounds to reduce free radical damage in mammals |
| 03/26/1997 | CN1145781A Kappa-opiate agonists for inflammatory bowel disorders |
| 03/26/1997 | CN1145780A Rapidly disintegrating medicinal form of tramadol or tramadol salt |
| 03/26/1997 | CN1145779A Medicine matrix and its use |
| 03/26/1997 | CN1145729A Health edible oil containing Alpha-linolenic acid |
| 03/26/1997 | CN1034334C Sodium diphenylglycolic phthalate and medical composition contg. same |
| 03/26/1997 | CN1034333C Prepn. of imidazopyrazole derivatives as analgesics and anti-inflammatory agents |
| 03/26/1997 | CN1034332C Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and method of producing them |
| 03/26/1997 | CN1034331C Prepn. of amines and acid additive salt thereof |
| 03/26/1997 | CN1034329C Prepn. of novel substituted propargyl zazcyclobutanone |
| 03/26/1997 | CA2186086A1 Substituted xanthines |
| 03/25/1997 | US5614651 Nonhygroscopic |
| 03/25/1997 | US5614649 Treatment of muscular disorders, substituted guanidines |
| 03/25/1997 | US5614645 Methods for making 2-debenzoyl and -2-acyl taxol derivatives |
| 03/25/1997 | US5614632 Process for the preparation of leukotriene anatgonists |
| 03/25/1997 | US5614631 1-alkyl-,1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds |
| 03/25/1997 | US5614630 Neurotransmitter release modulator |
| 03/25/1997 | US5614628 Antitumor |
| 03/25/1997 | US5614625 Collagenase inhibitors |
| 03/25/1997 | US5614623 Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate and processes for their preparation |
| 03/25/1997 | US5614621 Process for preparing oligonucleotides using silyl-containing diamino phosphorous reagents |
| 03/25/1997 | US5614615 Sialyl Lewis X mimetics incorporating fucopeptides |
| 03/25/1997 | US5614614 Antibiotics, chemical intermediates |
| 03/25/1997 | US5614583 Homogenized flowable hydrogel of crosslinked N-vinyl lactam polymer |
| 03/25/1997 | US5614562 Method of treating drug resistant tumor cells using organoselenones |
| 03/25/1997 | US5614561 Pyruvic acid and derivatives, fatty acid, topical |
| 03/25/1997 | US5614560 Method of preventing NMDA receptor-mediated neuronal damage |
| 03/25/1997 | US5614559 Compound for inhibiting HIV infectivity |
| 03/25/1997 | US5614558 Ethanolamine compounds, cocoamphocarboxyglycinate with water |
| 03/25/1997 | US5614557 Method of controlling tumor growth rate |
| 03/25/1997 | US5614556 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
| 03/25/1997 | US5614555 Amidinophenol derivatives |
| 03/25/1997 | US5614554 Retrovirus, sulfated tyrosine |
| 03/25/1997 | US5614553 Composition and method for alleviating stress in warm-blooded animals |
| 03/25/1997 | US5614551 Inhibitors of fatty acid synthesis as antimicrobial agents |
| 03/25/1997 | US5614550 Anticholesterol agents or arteriosclerosis agents for humans |